secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2022-08-29T23:59:59+00:00
Accession:  0001193125-22-231825
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences eliminates COO role; Glenn Coleman to exit Oct 3, 2022
---------------------------------------------------------------------------

- COO position eliminated effective October 3, 2022.
- Glenn Coleman, current COO, will cease employment on that date.
- Action is part of succession planning following the 2021 CEO transition.
- No replacement named for the eliminated role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000119312522231825/0001193125-22-231825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000119312522231825/d379797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-231825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer